Table 2 COVID-19 patients

Sex (F/M)

17/15

14/15

7/6

38/36

Age (years), mean (st. dev.)

63.5 (± 13.8)

65.4 (± 13.7)

65.1 (± 10.1)

64.5 (± 13.1)

BMI, mean (st. dev.)

29.5 (± 7.5)

27.1 (± 4.2)

31.4 (± 7.6)

28.9 (± 6.6)

FT3 (pg/ml), mean (st. dev.)

2.2 (± 0.4)

1.5 (± 0.1)

1.0 (± 0.0)

1.7 (± 0.6)

FT4 (ng/dl), mean (st. dev.)

1.0 (± 0.2)

1.0 (± 0.2)

0.9 (± 0.2)

1.0 (± 0.2)

TSH (μIU/ml), mean (st. dev.)

1.4 (± 1.3)

0.8 (± 0.9)

0.6 (± 0.8)

1.0 (± 1.1)

Comorbidity (at least one) n. (%)

26 (81.3)

24 (82.7)

13 (100)

63 (85.1)

Hypertension, n. (%)

23 (71.9)

17 (58.6)

11 (84.6)

51 (68.9)

Diabetes, n. (%)

15 (46.9)

8 (27.6)

6 (46.2)

29 (39.2)

Obesity, n. (%)

9 (28.1)

4 (13.8)

5 (38.5)

18 (24.3)

Malignancy, n. (%)

2 (6.3)

6 (20.7)

8 (19)

16 (21.6)

Ischemic heart disease, n. (%)

8 (25.0)

5 (17.2)

1 (7.7)

14 (18.9)

Arrhythmogenic cardiac diseases, n. (%)

1 (3.1)

2 (6.9)

1 (7.7)

4 (5.4)

Autoimmune disease, n. (%)

2 (6.3)

2 (6.9)

0 (0)

4 (5.4)

Chronic obstructive pulmonary disease, n. (%)

2 (6.3)

1 (3.4)

0 (0)

3 (4.0)

Psychiatric disease, n. (%)

1 (3.1)

1 (3.4)

1 (7.7)

3 (4.0)